Study of Serum Apolipoprotein A1 and Apolipoprotein B100 in Ischemic Heart Disease

Journal Title: International Journal of Medical Research Professionals - Year 2017, Vol 3, Issue 5

Abstract

Background: Apolipoprotein A1 (Apo A1), the major apoprotein in HDL promotes reverse cholesterol transport producing an antiatherogenic effect in body. Apolipoprotein B100 (Apo B100) a major apolipoprotein of LDL has atherogenic property. The aim of the study is to evaluate concentrations of Apo A1 & Apo B100 in ischemic heart disease patients and healthy controls and also to establish the inter-relationships between Apo A1 & Apo B100 among the patients. Methods: A case control study carried out from October 2014 to August 2016 in the Department of Biochemistry in collaboration with Department of Medicine, Regional Institute of Medical Sciences, Imphal, Manipur. 60 ischemic heart disease (IHD) patients and 60 healthy controls were taken as the study population. The results were analysed by ELISA. Results: The results of this study agree with the previous findings of other studies that the serum levels of Apo A1 & Apo B100 are significantly altered between IHD patients and controls. However, no significant correlation has been found between these three cardiac biomarker in this study. Apolipoprotein B100 measurements provide useful information for IHD risk assessment. Conclusion: The present data considers the measurement of Apo B100 as an important screening tool for the risk assessment of ischemic heart disease. Therefore, this study suggests the need for routine measurement of Apo A1 & Apo B100 in the diagnosis of IHD and thus helps in early detection of myocardial damage which warrants timely intervention leading to lowered morbidity and mortality.

Authors and Affiliations

L. Shaini, Soumya Sharma, Sachin Deba, Tina Das, Victoria Laishram, Salam Rojen Singh

Keywords

Related Articles

Reversible Effect of Marijuana on the Rat Hippocampal Tissue

Introduction: THC (Δ – 9 – tetrahydrocannabiol) is considered the active ingredient of Marijuana and it has a neurotoxic effect on one of the most sensitive brain regions, hippocampus. Objective: The aim of the present w...

Assessment of the Level of Awareness and Knowledge of Interventional Radiology among Medical Students And Medical Interns at Tabuk University

Introduction: Interventional radiology (IR) is a clinical specialty that utilizes image guidance to perform minimally invasive diagnostic and therapeutic procedures. In the setting of rapid advances in the worldwide heal...

A Study on Clinical and Laboratory Profile of Dengue Fever in a Tertiary Care Hospital in Assam, India

Objective: Dengue is one of the most important emerging mosquito-borne viral disease, afflicting humanity in terms of morbidity and mortality. This study was designed to assess the clinical and laboratory profile of pati...

Assessment of Efficacy of Clonidine with Midazolam as Premedication Agent: A Comparative Study

Background: The present study was conducted to compare the efficacy of midazolam with clonidine as a premedication in children. Materials & Methods: This study was conducted in department of anaesthesia, Rajshree Medical...

Knowledge, Attitude and Practice (KAP) Regarding Diabetes Mellitus (DM) Cause, Risk Factor, Prevention and Management Among Nondiabetic (Non DM) Female in Tabuk City, Saudi Arabia (KSA)

Introduction: Diabetes mellitus has multiple types, Type Two (also known as Non-Insulin Dependent Diabetes Mellitus) most common type, accounting more than 90-95% of diabetic population. Saudi Arabia is one of the fastes...

Download PDF file
  • EP ID EP547545
  • DOI 10.21276/ijmrp.2017.3.5.027
  • Views 92
  • Downloads 0

How To Cite

L. Shaini, Soumya Sharma, Sachin Deba, Tina Das, Victoria Laishram, Salam Rojen Singh (2017). Study of Serum Apolipoprotein A1 and Apolipoprotein B100 in Ischemic Heart Disease. International Journal of Medical Research Professionals, 3(5), 133-136. https://europub.co.uk/articles/-A-547545